|1.||Tell, L A: 5 articles (04/2014 - 10/2011)|
|2.||Berg, Janice: 4 articles (04/2009 - 01/2008)|
|3.||Fischer, Carrie D: 3 articles (06/2015 - 01/2011)|
|4.||Morck, Douglas W: 3 articles (06/2015 - 01/2011)|
|5.||Lucas, Merlyn J: 3 articles (06/2015 - 01/2011)|
|6.||Wetzlich, S E: 3 articles (04/2014 - 10/2011)|
|7.||Clothier, K A: 3 articles (04/2012 - 10/2011)|
|8.||Griffith, R W: 3 articles (04/2012 - 10/2011)|
|9.||Riviere, J E: 3 articles (04/2012 - 10/2011)|
|10.||Baynes, R E: 3 articles (04/2012 - 10/2011)|
08/15/2006 - "Efficacy of tulathromycin for treatment of cattle with acute ocular Moraxella bovis infections."
01/01/2005 - "The efficacy of tulathromycin in the treatment of bovine respiratory disease (BRD) due to Mycoplasma bovis was determined following experimental infection. "
01/01/2005 - "Efficacy of tulathromycin in the treatment of bovine respiratory disease associated with induced Mycoplasma bovis infections in young dairy calves."
06/01/2015 - "In this challenge model it was not possible to prove the metaphylactic effect of tulathromycin administered 4 and 7 days prior to infection with H. "
01/01/2015 - "The administration of tulathromycin around the time of infection prevented the progression of disease in 100% of the animals. "
06/01/2007 - "An evaluation of the relative efficacy of tulathromycin for the treatment of undifferentiated fever in feedlot calves in Nebraska."
01/01/2008 - "The purpose of this study was to compare the relative cost-effectiveness of florfenicol with that of tulathromycin for treatment of undifferentiated fever (UF) in feedlot calves at ultra-high risk of developing UF that receive metaphylactic tulathromycin on arrival at the feedlot. "
01/01/2008 - "Comparison of florfenicol and tulathromycin for the treatment of undifferentiated fever in Alberta feedlot calves."
06/01/2007 - "A field trial was performed under commercial feedlot conditions in central Nebraska to assess the relative efficacy of tulathromycin (TULA) to florfenicol (FLOR) for the treatment of undifferentiated fever (UF) in feedlot calves that did not receive a metaphylactic antimicrobial or vaccines/bacterins containing Mannheimia haemolytica or Histophilus somni at feedlot arrival by comparing animal health, feedlot performance, and carcass characteristic variables. "
01/01/2008 - "The purpose of this study was to compare the efficacy and cost-effectiveness of florfenicol versus tulathromycin for initial treatment of undifferentiated fever in fall-placed steer calves that received metaphylactic tilmicosin on arrival at the feedlot. "
|3.||Bovine Respiratory Disease Complex
06/01/2013 - "Field study of the comparative efficacy of gamithromycin and tulathromycin for the treatment of undifferentiated bovine respiratory disease complex in beef feedlot calves."
06/01/2013 - "To compare the efficacy of gamithromycin with that of tulathromycin for the treatment of undifferentiated bovine respiratory disease complex (BRDC) in feedlot calves. "
06/01/2013 - "To compare the efficacy of gamithromycin with that of tulathromycin for control of undifferentiated bovine respiratory disease complex (BRDC) in feedlot calves. "
06/01/2013 - "Field study of the comparative efficacy of gamithromycin and tulathromycin for the control of undifferentiated bovine respiratory disease complex in beef feedlot calves at high risk of developing respiratory tract disease."
08/15/2006 - "A single dose of tulathromycin (SC) was an effective treatment of calves with experimentally induced infectious bovine keratoconjunctivitis. "
08/15/2006 - "To evaluate the clinical efficacy of a single injection of tulathromycin, compared with saline (0.9% NaCl) solution-treated control calves, for treatment of induced infectious bovine keratoconjunctivitis in calves. "
08/15/2006 - "The long serum half-life of tulathromycin, along with the results of this trial, suggests that tulathromycin may be a rational choice as a single-injection treatment for infectious bovine keratoconjunctivitis."
06/01/2014 - "Tulathromycin is approved in the United States for the treatment of respiratory disease in bovine and swine, infectious bovine keratoconjunctivitis associated with Moraxella bovis, and interdigital necrobacillosis in bovine. "
11/01/2013 - "The discovery of tulathromycin and its registration in multiple countries has been important for the food animal industry as it has been used successfully to treat economically important conditions such as bovine and porcine respiratory disease, infectious bovine keratoconjunctivitis and interdigital necrobacillosis. "
|5.||Body Weight (Weight, Body)
01/01/2005 - "In each study, feeder pigs with clinical SRD were randomly assigned in equal numbers to a group treated with tulathromycin given as a single injection at 2.5 mg/kg of body weight or to a saline-treated control group. "
01/01/2005 - "In each study, 100 calves with BRD were treated with tulathromycin given SC at 2.5 mg/kg body weight. "
04/01/2014 - "Eight adult female dairy goats received one subcutaneous administration of tulathromycin at a dosage of 2.5 mg/kg body weight. "
12/01/2013 - "Six goats were administered a single dose of tulathromycin at 2.5 mg/kg of body weight subcutaneously, while the other six received the same dose by injection directly into the inoculated chambers. "
06/01/2012 - "Eight pigs, with body weight of 20.5 ± 1.6 kg, were given a single dose of tulathromycin at 2.5 mg/kg oral (p.o.) and intravenous (i.v.) in a crossover design. "
|3.||flunixin meglumine (Banamine)
|10.||Anti-Bacterial Agents (Antibiotics)